[1]
|
Benjamin, E.J., Virani, S.S., Callaway, C.W., Chamberlain, A.M., Chang, A.R., Cheng, S., et al. (2018) Heart Disease and Stroke Statistics—2018 Update: A Report from the American Heart Association. Circulation, 137, e67-e492.
https://doi.org/10.1161/CIR.0000000000000573
|
[2]
|
Schade, D.S. and Eaton, R.P. (2019) A Simplified Approach to Reducing Cardiovascular Risk. The Journal of Clinical Endocrinology & Metabolism, 104, 6033-6039.
|
[3]
|
Cholesterol Treatment Trialists’ (CTT) Collaborators, Mihaylova, B., Emberson, J., Blackwell, L., Keech, A., Simes, J., Barnes, E.H., et al. (2012) The Effects of Lowering LDL Cholesterol with Statin Therapy in People at Low Risk of Vascular Disease: Meta-Analysis of Individual Data from 27 Randomised Trials. The Lancet, 380, 581-590.
https://doi.org/10.1016/S0140-6736(12)60367-5
|
[4]
|
Eaton, R.P., Burge, M.R., Comerci, G., Cavanaugh, B., Ramo, B. and Schade, D.S. (2016) Abnormal Coronary Artery Calcium Scans in Asymptomatic Patients. The American Journal of Medicine, 130, 394-397. https://doi.org/10.1016/j.amjmed.2016.10.006
|
[5]
|
Miksenas, H., Januzzi, J.L. and Natarajan, P. (2021) Lipoprotein(a) and Cardiovascular Diseases. Journal of the American Medical Association, 326, 352-353.
https://doi.org/10.1001/jama.2021.3632
|
[6]
|
Ridker, P.M. (2001) High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease. Circulation, 103, 1813-1818. https://doi.org/10.1161/01.CIR.103.13.1813
|
[7]
|
Min, J.K., Shaw, L.J., Devereux, R.B., Okin, P.M., Weinsaft, J.W., Russo, D.J., et al. (2007) Prognostic Value of Multidetector Coronary Computed Tomographic Angiography for Prediction of All-Cause Mortality. Journal of the American College of Cardiology, 50, 1161-1170. https://doi.org/10.1016/j.jacc.2007.03.067
|
[8]
|
Schade, D.S., Gonzales, K., Kaminsky, N., Adolphe, A., Shey, L. and Eaton R.P. (2022) Resolving the Egg and Cholesterol Intake Controversy: New Clinical Insights into Cholesterol Regulation by the Liver and Intestine. Endocrine Practice, 28, 102-109.
https://doi.org/10.1016/j.eprac.2021.09.004
|
[9]
|
Baigent, C., Keech, A., Kearney, P.M., Blackwell, L., Buck, G., Pollicino, C. and The Cholesterol Treatment Trialists’ (CTT) Collaborators (2005) Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90,056 Participants in 14 Randomised Trials of Statins. The Lancet, 366, 1267-1278.
https://doi.org/10.1016/S0140-6736(05)67394-1
|
[10]
|
Al Rifai, M., Cainzos-Achirica, M. and Blaha, M.J. (2015) Establishing the Warranty of a Coronary Artery Calcium Score of Zero. Atherosclerosis, 238, 1-3.
https://doi.org/10.1016/j.atherosclerosis.2014.10.084
|
[11]
|
Callister, T.Q., Raggi, P., Cooil, B., Lippolis, N.J. and Russo, D.J. (1998) Effect of HMG- CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed Tomography. The New England Journal of Medicine, 339, 1972-1978.
https://doi.org/10.1056/NEJM199812313392703
|
[12]
|
Hecht, H., Blaha, M.J., Berman, D.S., Nasir, K., Budoff, M., Leipsic, J., et al. (2017) Clinical Indications for Coronary Artery Calcium Scoring in Asymptomatic Patients: Expert Consensus Statement from the Society of Cardiovascular Computed Tomography. Journal of Cardiovascular Computed Tomography, 11, 157-168.
https://doi.org/10.1016/j.jcct.2017.02.010
|
[13]
|
Vliegenthart, R., Oudkerk, M., Hofman, A., et al. (2005) Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly. Circulation, 112, 572-577.
https://doi.org/10.1161/CIRCULATIONAHA.104.488916
|
[14]
|
Budoff, M.J., Young, R., Burke, G., Carr, J.J., Detrano, R.C., et al. (2018) Ten-Year Association of Coronary Artery Calcium with Atherosclerotic Cardiovascular Disease (ASCVD) Events: The Multi-Ethnic Study of Atherosclerosis (MESA). European Heart Journal, 39, 2401-2408. https://doi.org/10.1093/eurheartj/ehy217
|
[15]
|
Malik, S., Budoff, M.J., Katz, R., Blumenthal, R.S., Bertoni, A.G., Nasir, K., Szklo, M., Barr, R.G. and Wong, N.D. (2011) Impact of Subclinical Atherosclerosis on Cardiovascular Disease Events in Individuals with Metabolic Syndrome and Diabetes. Diabetes Care, 34, 2285-2290. https://doi.org/10.2337/dc11-0816
|
[16]
|
Mora, S., Rifai, N., Buring, J.E. and Ridker, P.M. (2009) Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27,331 Women. Clinical Chemistry, 55, 888-894.
https://doi.org/10.1373/clinchem.2008.117929
|
[17]
|
Stangroom, J. (2018) Social Science Statistics.
https://www.socscistatistics.com
|
[18]
|
Sanders, J. and Stacy, A. (2021) Good Calculators: Free Online Calculators.
https://goodcalculators.com
|
[19]
|
Schade, D.S., Cavanaugh, B., Ramo, B. and Eaton, R.P. (2016) The Application of the LDL Principle. World Journal of Cardiovascular Diseases, 6, 109-125.
https://doi.org/10.4236/wjcd.2016.65012
|
[20]
|
Nakamura, T., Obata, J.E., Kitta, Y., Takano, H., Kobayashi, T., Fujioka, D., Saito, Y., Kodama, Y., Kawabata, K., Mende, A., Yano, T., Hirano, M., Sano, K., Nakamura, K., Kugiyama, K., et al. (2008) Rapid Stabilization of Vulnerable Carotid Plaque within 1 Month of Pitavastatin Treatment in Patients with Acute Coronary Syndrome. Journal of Cardiovascular Pharmacology, 51, 365-371.
https://doi.org/10.1097/FJC.0b013e318165dcad
|
[21]
|
Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., et al. (1995) Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. The New England Journal of Medicine, 333, 1301-1308.
https://doi.org/10.1056/NEJM199511163332001
|
[22]
|
Downs, J.R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D.R., Beere, P.A., et al. (1998) Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels: Results of AFCAPS/TexCAPS Research. Journal of the American Medical Association, 279, 1615-1622.
https://doi.org/10.1001/jama.279.20.1615
|
[23]
|
Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., The HOPE-3 Investigators, et al. (2016) Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. The New England Journal of Medicine, 374, 2021-2031.
https://doi.org/10.1056/NEJMoa1600176
|
[24]
|
Nissen, S.E., Nicholls, S.J., Sipahi, I., Libby, P., Raichlen, J.S., Ballantyne, C.M., Davignon, J., Erbel, R., Fruchart, J.C., Tardif, J.C., Schoenhagen, P., Crowe, T., Cain, V., Wolski, K., Goormastic, M., Tuzcu, E.M., The ASTEROID Investigators, et al. (2006) Effect of very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis—The ASTEROID Trial. Journal of the American Medical Association, 295, 1556- 1565. https://doi.org/10.1001/jama.295.13.jpc60002
|
[25]
|
Nicholls, S.J., Ballantyne, C.M., Barter, P.J., Chapman, J., Erbel, R.M., Libby, P., et al. (2011) Effect of Two Intensive Statin Regimens on Progression of Coronary Disease. The New England Journal of Medicine, 365, 2078-2087.
https://doi.org/10.1056/NEJMoa1110874
|
[26]
|
Gao, W.Q., Feng, Q.Z., Li, Y.F., Li, Y.X., Huang, Y., Chen, Y.M., et al. (2014) Systematic Study of the Effects of Lowering Low-Density Lipoprotein-Cholesterol on Regression of Coronary Atherosclerotic Plaques Using Intravascular Ultrasound. BMC Cardiovascular Disorders, 14, Article No. 60.
https://doi.org/10.1186/1471-2261-14-60
|
[27]
|
Valenti, V., Hartaigh, B.O., Heo, R., Cho, I., Schulman-Marcus, J., Gransar, H., et al. (2015) A 15-Year Warranty Period for Asymptomatic Individuals without Coronary Artery Calcium. JACC: Cardiovascular Imaging, 8, 900-909.
https://doi.org/10.1016/j.jcmg.2015.01.025
|
[28]
|
Nasir, K., Rubin, J., Blaha, M.J., Shaw, L.J., Blankstein, R., Rivera, J.J., et al. (2012) Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals. Circulation: Cardiovascular Imaging, 5, 467-473. https://doi.org/10.1161/CIRCIMAGING.111.964528
|
[29]
|
Blaha, M.J., Silverman, M.G. and Budoff, M.J. (2014) Is there a Role for Coronary Artery Calcium Scoring for Management of Asymptomatic Patients at Risk for Coronary Artery Disease? Clinical Risk Scores Are Not Sufficient to Define Primary Prevention Treatment Strategies among Asymptomatic Patients. Circulation: Cardiovascular Imaging, 7, 398-408. https://doi.org/10.1161/CIRCIMAGING.113.000341
|
[30]
|
Roberts, E.T., Horne, A., Martin, S.S., Blaha, M.J., Blankstein, R., Budoff, M.J., et al. (2015) Cost-Effectiveness of Coronary Artery Calcium Testing for Coronary Heart and Cardiovascular Disease Risk Prediction to Guide Statin Allocation: The Multi-Eth- nic Study of Atherosclerosis (MESA). PLoS ONE, 10, e0116377.
https://doi.org/10.1371/journal.pone.0116377
|
[31]
|
Kalia, N.K., Cespedes, L., Youssef, G., Li, D. and Budoff, M.J. (2015) Motivational Effects of Coronary Artery Calcium Scores on Statin Adherence and Weight Loss. Coronary Artery Disease, 26, 225-230. https://doi.org/10.1097/MCA.0000000000000207
|
[32]
|
Schmermund, A., Baumgart, D., Gorge, G., Seibel, R., Gronemeyer, D., et al. (1997) Coronary Artery Calcium in Acute Coronary Syndromes: A Comparative Study of Electron-Beam Computed Tomography, Coronary Angiography, and Intracoronary Ultrasound in Survivors of Acute Myocardial Infarction and Unstable Angina. Circulation, 96, 1461-1469. https://doi.org/10.1161/01.CIR.96.5.1461
|
[33]
|
Braunwald, E. (2013) Coronary Plaque Erosion: Recognition and Management. JACC: Cardiovascular Imaging, 6, 288-289. https://doi.org/10.1016/j.jcmg.2013.01.003
|
[34]
|
Arnett, D.K., Blumenthal, R.S., Albert, M.A., Michos, E.D., Buroker, A.B., Miedema, M.D., et al. (2019) 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 74, e177-e232. https://doi.org/10.1016/j.jacc.2019.03.010
|
[35]
|
Schade, D.S., Arora, S. and Eaton, R.P. (2020) Should Routine Screening for Coronary Artery Disease Be Recommended? A Comparison with Routine Screening for Colon Cancer. The American Journal of Medicine, 133, 155-157.
|
[36]
|
Olsson, A.G., Pears, J., McKellar, J., Mizan, J. and Raza, A. (2001) Effect of Rosuvastatin on Low-Density Lipoprotein Cholesterol in Patients with Hypercholesterolemia. The American Journal of Cardiology, 88, 504-508.
|
[37]
|
Gagne Gagné, C., Bays, H.E., Weiss, S.R., Mata, P., Quinto, K., Melino, M., The Ezetimibe Study Group, et al. (2002) Efficacy and Safety of Ezetimibe Added to Ongoing Statin Therapy for Treatment of Patients with Primary Hypercholesterolemia. The American Journal of Cardiology, 90, 1084-1091.
|
[38]
|
Schonfeld, G., Patsch, W., Rudel, L.L., Nelson, C., Epstein, M. and Olson, R.E. (1982) Effects of Dietary Cholesterol and Fatty Acids on Plasma Lipoproteins. Journal of Clinical Investigation, 69, 1072-1080. https://doi.org/10.1172/JCI110542
|
[39]
|
O’Keefe, J.H., Cordain, L., Harris, W.H., Moe, R.M. and Vogel, R. (2004) Optimal Low- Density Lipoprotein Is 50 to 70 mg/dl: Lower Is Better and Physiologically Normal. Journal of the American College of Cardiology, 43, 2142-2146.
https://doi.org/10.1016/j.jacc.2004.03.046
|
[40]
|
Karagiannis, A.D., Mehta, A., Dhindsa, D.S., Virani, S.S., Orringer, C.E., et al. (2021) How Low Is Safe? The Frontier of very Low (<30 mg/dL) LDL Cholesterol. European Heart Journal, 42, 2154-2169. https://doi.org/10.1093/eurheartj/ehaa1080
|
[41]
|
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., et al. (2016) Interpretation of the Evidence for the Efficacy and Safety of Statin Therapy. The Lancet, 388, 2532-2561. https://doi.org/10.1016/S0140-6736(16)31357-5
|
[42]
|
Kataoka, Y., John, J., Wolski, K., Uno, K., Puri, R., Tuzcu, E.M., Nissen, S.E. and Nicholls, S.J. (2015) Atheroma Progression in Hyporesponders to Statin Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 990-995.
https://doi.org/10.1161/ATVBAHA.114.304477
|